These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1699550)

  • 1. T-cell mediated autoimmunity: molecular interactions and therapeutic implications.
    Linington C; Hohlfeld R
    J Autoimmun; 1990 Aug; 3(4):501-6. PubMed ID: 1699550
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.
    Fairchild PJ; Thorpe CJ; Travers PJ; Wraith DC
    Immunology; 1994 Apr; 81(4):487-96. PubMed ID: 7518791
    [No Abstract]   [Full Text] [Related]  

  • 3. On the mark: genetically engineered immunotherapies for autoimmunity.
    Ellebrecht CT; Lundgren DK; Payne AS
    Curr Opin Immunol; 2019 Dec; 61():69-73. PubMed ID: 31563849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
    Tisch R; McDevitt HO
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):437-8. PubMed ID: 8290544
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid autoimmunity.
    Champion BR; Cooke A; Rayner DC
    Curr Opin Immunol; 1992 Dec; 4(6):770-8. PubMed ID: 1466801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmunity and the kidney.
    Oliveira DB; Peters DK
    Kidney Int; 1989 Apr; 35(4):923-8. PubMed ID: 2651769
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptide-MHC interaction in autoimmunity.
    Fairchild PJ; Wraith DC
    Curr Opin Immunol; 1992 Dec; 4(6):748-53. PubMed ID: 1466798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists.
    Nielsen HJ; Hammer JH
    Med Hypotheses; 1992 Dec; 39(4):349-55. PubMed ID: 1362972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of autoantigens in the driving of autoimmune diseases.
    Roitt IM
    Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity: present-day concepts and future prospects.
    Hong R
    Curr Probl Pediatr; 1991 Jul; 21(6):253-8. PubMed ID: 1914513
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of autoantigens in autoimmune disease.
    Mocci S; Lafferty K; Howard M
    Curr Opin Immunol; 2000 Dec; 12(6):725-30. PubMed ID: 11102779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes.
    Möller E; Böhme J; Valugerdi MA; Ridderstad A; Olerup O
    Immunol Rev; 1990 Dec; 118():5-19. PubMed ID: 1706682
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunospecific drug design--prospects for treatment of autoimmune diseases.
    Arnon R; Teitelbaum D
    Ther Immunol; 1994 Jan; 1(1):65-70. PubMed ID: 7584481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in autoimmune diseases.
    Miller A; Hafler DA; Weiner HL
    Curr Opin Immunol; 1991 Dec; 3(6):936-40. PubMed ID: 1793539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity.
    Carl PL; Temple BR; Cohen PL
    Arthritis Res Ther; 2005; 7(6):R1360-74. PubMed ID: 16277689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
    Acha-Orbea H
    Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.